Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 5, 1997, Pages 409-414

  Hare, C Bradley ^a   Elion, Gertrude B ^a   Colvin, O Michael ^a   Ali Osman, Francis ^b   Griffith, Owen W ^c   Petros, William P ^a   Keir, Stephen ^a   Marcelli, Susan L ^a   Bigner, Darell D ^a   Friedman, Henry S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Busulfan; Drug resistance; Glioblastoma multiforme; Xenograft

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IRINOTECAN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHILD; CONTROLLED STUDY; CROSS RESISTANCE; DRUG TUMOR LEVEL; FEMALE; GENE AMPLIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BLOTTING, SOUTHERN; BUSULFAN; DRUG RESISTANCE, NEOPLASM; FEMALE; GLIOBLASTOMA; GLUTAMATE-CYSTEINE LIGASE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; TRANSPLANTATION, HETEROLOGOUS;

EID: 8544277976     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050678     Document Type: Article

References (39)

1. Aaron RH, Elion GB, Colvin OM, Graham M, Keir S, Bigner DD, Friedman HS (1994) Busulfan therapy of central nervous system xenografts in athymic mice. Cancer Chemother Pharmacol 35: 127
2. Ahmad S, Okine L, Le B, Najarian P, Vistica DT (1987) Elevation of glutathione in phenylalanine mustard-resistant murine L1210 leukemia cells. J Biol Chem 262: 15048
3. Ali-Osman F, Berger MS, Rajagopal S, Spence A, Livingston RB (1993) Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin induced DNA interstrand crosslinks and cytotoxicity in human glioblastoma cells. Cancer Res 53: 5663
4. Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E (1996) Buthionine sulfoximine induction of γ-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA crosslinking and cytotoxicity in human glioma cells. Mol Pharmacol 49: 1012
5. Bigner SH, Mark J, Schold SC Jr, Eng LF, Bigner DD (1985) A serially transplantable human giant cell glioblastoma that maintains a near haploid stem line. Cancer Chemother Pharmacol 8: 3
6. Bolin RW, Robinson WA, Sutherland J, Hamman RF (1982) Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia. Cancer 50: 1683
7. Buggia I, Locatelli F, Regazzi MB, Zecca M (1994) Busulfan. Ann Pharmacother 28: 1055
8. Bullard DE, Bigner DD (1979) The heterotransplantation of human craniopharyngiomas in athymic "nude" mice. Neurosurgery 4: 308
9. Butler AL, Clapper ML, Tew KD (1987) Glutathione-S-transferase in nitrogen mustard-resistant and -sensitive cell lines. Mol Pharmacol 31: 575
10. Calcutt G, Conners TA (1963) Tumor sulfhydryl levels and sensitivity to the nitrogen mustard merophan. Biochem Pharmacol 12: 839
11. Calsou P, Salles B (1993) Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin. Cancer Chemother Pharmacol 32: 85
12. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156
13. Colvin OM, Friedman HS, Gamcsik MP, Fenselau C, Hilton J (1993) Role of glutathione in cellular resistance to alkylating agents. Adv Enzyme Regul 33: 19
14. Dong Q, Bullock N, Ali-Osman F, Colvin OM, Bigner DD, Friedman HS (1996) Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines. Cancer Chemother Pharmacol 37: 242
15. Dunn CDR (1974) The chemical and biological properties of busulphan (Myleran). Exp Hematol 2: 101
16. Friedman HS, Colvin OM, Skapek SX, Ludeman SM, Elion GB, Schold SC Jr, Jacobsen PF, Muhlbaier LH, Bigner DD (1988) Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Res 48: 4189
17. Friedman HS, Skapek SX, Colvin OM, Elion GB, Blum MR, Savina PM, Hamilton J, Schold SC Jr, Kurtzberg J, Bigner DD (1988) Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma. Cancer Res 48: 5397
18. Friedman HS, Colvin OM, Kaufman SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW (1992) Cyclophosphamide resistance in medulloblastoma. Cancer Res 32: 5373
19. Friedman HS, Dolan ME, Moschel RC, Pegg AE, Felker GM, Rich J, Bigner DD, Schold SC Jr (1992) Enhancement of nitrosourea activity in medulloblastoma and glioblastoma multiforme. J Natl Cancer Inst 84: 1926
20. Friedman HS, Dolan ME, Kaufmann SH, Colvin OM, Griffith OW, Moschel RC, Schold SC, Bigner DD, Ali-Osman F (1994) Elevated DNA polymerase α, DNA polymerase β, and DNA topoisomerase in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topolecan. Cancer Res 54: 3487
21. Galton DGA (1953) Myleran in chronic myeloid leukemia: results of the treatment. Lancet 1: 208
22. Gipp JJ, Chang C, Mulcahey T (1992) Cloning and nucleotide sequence of a full-length cDNA for human liver γ-glutamylcysteine synthetase. Biochem Biophys Res Commun 185: 29
23. Graham ML, Chaffee S, Kurtzberg J, Guaspari A, Friedman HS (1993) A Phase I-II study of high-dose melphalan and cyclophosphamide with autologous bone marrow and/or stem cell rescue for patients with high-risk CNS tumors. Proc Annu Meet Am Soc Clin Oncol 12: A523
24. Griffith OW (1980) Determinations of glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106: 207
25. Griffith OW (1982) Mechanism of action, metabolism and toxicity of buthionine sulfoximine and its higher homologs. potent inhibitors of glutathione synthesis. J Biol Chem 257: 13701
26. Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130
27. Hare CB, Elion GB, Houghton PJ, Houghton JA, Keir S, Marcelli SL, Bigner DD, Friedman HS (1997) Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts. Cancer Chemother Pharmacol 39: 187
28. Hehlmann R (1988) Cytostatic therapy in chronic myelogenous leukemia: review and perspectives. In: Huhn D, Hellriegell KP, Niederle N (eds) Chronic myelocytic leukemia and interferon. Springer Verlag, Berlin, p 102
29. Hilton J (1984) Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia. Cancer Res 44: 5156
30. Kalifa C, Hartmann O, Demeocq F, Vassel G, Couanet D, Terrier-Lacombe MJ, Valteau D, Brugieres L, Lemerle J (1992) High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant 9: 227
31. MacKichan JJ, Bechtel TP (1990) Quantitation of busulfan in plasma by high-performance liquid chromatography. J Chromatogr 532: 424
32. McGown AT, Fox BW (1986) A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. Cancer Chemother Pharmacol 17: 223
33. Parkman R, Rappeport JM, Hellman S, Lipton J, Smith B, Geha R (1984) Busulfan and total body irradiation as antihaemopoietic stem cell agents in the preparation of patients with congenital bone marrow disorders for allogeneic bone marrow transplantation. Blood 64: 852
34. Robson CN, Lewis AD, Wolf CR, Hayes JD, Hall A, Proctor SJ, Harris AL, Hickson ID (1987) Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione-S-transferase activity. Cancer Res 47: 6022
35. Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DD, Friedman HS (1989) Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion. Cancer Res 49: 6917
36. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning - A laboratory manual. Cold Spring Harbor Laboratory Press
37. Susukaka D, Petro BJ, Vistica DT (1982) Reduction in glutathione content of L-PAM resistant L1210 cell confers drug sensitivity. Biochem Pharmacol 31: 121
38. Tew KD, Clapper ML (1988) Gluathione-S-transferase and anticancer drug resistance. In: Wooley PV, Tew KD (eds) Mechanisms of drug resistance, Academic Press, San Diego, p 141
39. Tielze F (1969) Enzymic method for quantitative determination of nanognim amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27: 502